Sandesh Mahatme
2013
In 2013, Sandesh Mahatme earned a total compensation of $3.9M as Senior Vice President, Chief Financial Officer at Sarepta Therapeutics, a 20% decrease compared to previous year.
Compensation breakdown
| Bonus | $30,000 |
|---|---|
| Non-Equity Incentive Plan | $213,945 |
| Option Awards | $3,129,435 |
| Salary | $427,167 |
| Other | $78,523 |
| Total | $3,879,070 |
Mahatme received $3.1M in option awards, accounting for 81% of the total pay in 2013.
Mahatme also received $30K in bonus, $213.9K in non-equity incentive plan, $427.2K in salary and $78.5K in other compensation.
Rankings
In 2013, Sandesh Mahatme's compensation ranked 1,826th out of 12,286 executives tracked by ExecPay. In other words, Mahatme earned more than 85.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,826 out of 12,286 | 85th |
Division Manufacturing | 597 out of 4,614 | 87th |
Major group Chemicals And Allied Products | 163 out of 1,466 | 89th |
Industry group Drugs | 110 out of 1,160 | 91st |
Industry Pharmaceutical Preparations | 94 out of 890 | 89th |
Source: SEC filing on May 31, 2016.
Mahatme's colleagues
We found four more compensation records of executives who worked with Sandesh Mahatme at Sarepta Therapeutics in 2013.